Cover Image

Living at genetic risk: The patient experience of Lynch syndrome

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Nicola Reents, Georgina Hoffmann, Kelly Kohut
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	International Journal of Cancer
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Integrative omics approaches to uncover liquid‐based cancer‐predicting biomarkers in Lynch syndrome
by: Minta Kärkkäinen, et al.
Published: (2025)

Organ‐sparing strategies in patients with MSI / dMMR tumors including Lynch syndrome: Current state of the art and future perspectives for clinical decision‐making
by: Martin Duval, et al.
Published: (2025)

Acceptability and somatic mutations in cervicovaginal self‐sampling for early endometrial cancer detection in women with Lynch syndrome
by: Paula Peremiquel‐Trillas, et al.
Published: (2025)

Outcomes from the English National Lynch Syndrome transformation project
by: Kevin J. Monahan, et al.
Published: (2026)

Family history and genetic risk score combined to guide cancer risk stratification: A prospective cohort study
by: Chen Ji, et al.
Published: (2024)

Baseline vitamin D status, genetic susceptibility, and the risk of incident hepatocellular carcinoma
by: Chengxiao Yu, et al.
Published: (2025)

Deciphering the folate puzzle: Unraveling the impact of genetic variations and metabolites on cancer risk
by: Tong Liu, et al.
Published: (2024)

Integrating multi‐ancestry genomic and proteomic data to identify blood risk biomarkers and target proteins for breast cancer genetic risk loci
by: Guochong Jia, et al.
Published: (2025)

Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathway
by: Michiel Vlaming, et al.
Published: (2025)

Artificial Intelligence in Colonoscopy Surveillance for Lynch Syndrome: Emerging Evidence, Lessons Learned From Average‐Risk Populations, and Future Directions
by: Robert Hüneburg, et al.
Published: (2026)

Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer
by: Klara Hammarström, et al.
Published: (2024)

Outcomes and risk factors of hemorrhage in patients with resected brain metastases
by: Melisa S. Guelen, et al.
Published: (2025)

Role of the perinatal experience on the risk of acute leukemia in childhood or adolescence: Systematic review and meta‐analysis
by: Jessica Blanco‐Lopez, et al.
Published: (2025)

Combined effects of smoking and alcohol consumption on the risk of liver cancer according to metabolic syndrome: A nested case–control study in South Korea
by: Thi Tra Bui, et al.
Published: (2024)

Long‐term impact of stressful life events on breast cancer risk: A 36‐year genetically informed prospective study in the Finnish Twin Cohort
by: Elissar Azzi, et al.
Published: (2025)

Physical activity and risks of recurrence and progression among patients with non‐muscle invasive bladder cancer
by: Ivy Beeren, et al.
Published: (2025)

Prognostic impact of p16 and high‐risk HPV DNA in ~1300 patients with vulvar cancer
by: Susanne K. Kjær, et al.
Published: (2025)

Smoking behavior and the risks of tumor recurrence and progression in patients with non‐muscle‐invasive bladder cancer
by: Joann Kiebach, et al.
Published: (2024)

The risk of treatment‐related toxicities with PD‐1/PD‐L1 inhibitors in patients with lung cancer
by: Hao Hu, et al.
Published: (2024)

Comment on “Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients”
by: Gang Zhao, et al.
Published: (2024)

Reply to: Comments on “Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients”
by: Mi Na Kim, et al.
Published: (2024)

Clinical and genetic features of multiple primary tumours cohorts with a renal cell carcinoma: Implications for molecular genetic investigations
by: Huairen Zhang, et al.
Published: (2025)

Multilevel pathways to esophageal cancer: Population attributable risks of modifiable exposures, surrogate blood biomarkers, and genetic susceptibility, and the mediation effects based on a 10‐year prospective cohort study
by: Zixuan Cui, et al.
Published: (2026)

Personalized dendritic cell vaccine in multimodal individualized combination therapy improves survival in high‐risk pediatric cancer patients
by: Michal Kyr, et al.
Published: (2024)

Treatment outcomes in nasopharyngeal carcinoma patients with parotid lymph node metastasis: An 11‐year experience at a tertiary cancer center
by: Linghui Yan, et al.
Published: (2025)

Treatment patterns and clinical outcomes in real‐world patients with small‐cell lung cancer in South Korea: A single‐center experience
by: Sehhoon Park, et al.
Published: (2026)

Breast conserving surgery with intraoperative electron beam radiation therapy for low‐risk breast cancer: Five‐year follow‐up of 306 patients
by: Charlotte de Jonge, et al.
Published: (2024)

Integrating polygenic and methylation risk scores for pleural mesothelioma risk stratification
by: Khadija Sana Hafeez, et al.
Published: (2025)

Does the duration of diabetes increase the risk of cancer? A nationwide population‐based cohort of patients with new‐onset diabetes and a matched reference cohort
by: Petrus Lohi, et al.
Published: (2024)

Naxitamab with novel scheduling and stepped‐up dosing of GM ‐ CSF plus vaccine, but no myeloablative therapy for patients with high‐risk neuroblastoma in first complete remission
by: Brian H. Kushner, et al.
Published: (2026)

A phase II trial of naxitamab plus stepped‐up dosing of GM ‐ CSF for patients with high‐risk neuroblastoma in second or later complete remission
by: Brian H. Kushner, et al.
Published: (2026)

Alcohol and smoking habits in association with hepatocellular carcinoma risk
by: Elom K. Aglago, et al.
Published: (2025)

Nationwide implementation and evaluation of the Tumor‐First workflow for genetic testing in ovarian carcinoma
by: Vera M. Witjes, et al.
Published: (2025)

Prostate cancer characteristics in fathers and risk of early onset high‐risk prostate cancer in sons
by: E Lin, et al.
Published: (2025)

Cardiovascular disease incidence and cancer risk in two large European prospective cohorts
by: Emma Fontvieille, et al.
Published: (2026)

Long‐term risk of major cardiac events in breast cancer patients treated with intensity‐modulated and 3‐dimensional conformal radiotherapy: Secondary analysis of a randomized clinical trial
by: Nam Kyu Kang, et al.
Published: (2025)

Oral cancer risk stratification: A cross‐sectional population‐based screening study in Northeast India
by: Kunal Oswal, et al.
Published: (2025)

The risk of vaginal, vulvar and anal precancer and cancer according to high‐risk HPV status in cervical cytology samples
by: Sofie Lindquist, et al.
Published: (2024)

Body height and the excess cancer risk in men
by: Cecilia Radkiewicz, et al.
Published: (2025)

Linkage disequilibrium score regression identifies genetic correlations between hepatocellular carcinoma and clinically relevant traits
by: Younghun Han, et al.
Published: (2025)